What is the role of medications in the treatment of lecithin-cholesterol acyltransferase (LCAT) deficiency?

Updated: Oct 16, 2019
  • Author: Catherine Anastasopoulou, MD, PhD, FACE; Chief Editor: George T Griffing, MD  more...
  • Print


Pharmacologic therapy - Because of the rarity of LCAT deficiency, pharmacologic therapy has not been specifically studied in a systematic fashion; however, case studies have reported benefit with statins and angiotensin receptor blockers in renal disease with LCAT. [13]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!